Gilead CEO expects remdesivir to effectively treat Covid strains found in U.K., South Africa
January 11, 2021 at 08:53 AM EST
"I expect remdesivir with these variants will continue to make an impact on patients," Gilead Sciences CEO Daniel O'Day told CNBC.
